Eris Lifesciences Limited (ERIS) — Capital Reinvestment Ratio
Eris Lifesciences Limited (ERIS) has a Capital Reinvestment Ratio of 0.49x as of September 2025, meaning it reinvests 0% of its operating cash flow (Rs2.39 Billion) in capital expenditures (Rs1.17 Billion). See Eris Lifesciences Limited (ERIS) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Eris Lifesciences Limited Capital Reinvestment Ratio (2012–2025)
This chart tracks Eris Lifesciences Limited's Capital Reinvestment Ratio across 14 annual periods. Check ERIS cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Eris Lifesciences Limited (2012–2025)
Year-by-year Capital Reinvestment Ratio for Eris Lifesciences Limited from 2012 to 2025. For live market cap and broader valuation context, see ERIS company net worth.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | Rs10.65 Billion | Rs1.55 Billion | ▼ -45.2% |
| 2024 | 0.27x | Rs4.86 Billion | Rs1.29 Billion | ▼ -90.8% |
| 2023 | 2.88x | Rs2.92 Billion | Rs8.41 Billion | ▲ +801.4% |
| 2022 | 0.32x | Rs3.78 Billion | Rs1.21 Billion | ▲ +366.2% |
| 2021 | 0.07x | Rs3.75 Billion | Rs257.63 Million | ▼ -87.7% |
| 2020 | 0.56x | Rs2.71 Billion | Rs1.51 Billion | ▲ +227.4% |
| 2019 | 0.17x | Rs2.23 Billion | Rs380.02 Million | ▲ +59.3% |
| 2018 | 0.11x | Rs2.35 Billion | Rs250.96 Million | ▼ -57.0% |
| 2017 | 0.25x | Rs2.00 Billion | Rs497.47 Million | ▲ +38.4% |
| 2016 | 0.18x | Rs1.31 Billion | Rs236.41 Million | ▲ +23.8% |
| 2015 | 0.15x | Rs900.57 Million | Rs130.84 Million | ▼ -74.9% |
| 2014 | 0.58x | Rs896.24 Million | Rs519.33 Million | ▲ +180.9% |
| 2013 | 0.21x | Rs380.15 Million | Rs78.43 Million | ▼ -5.8% |
| 2012 | 0.22x | Rs302.99 Million | Rs66.39 Million | — |